DOSIERFORMEN FÜR ARZNEIMITTEL

Patent europeic · EP3166596 · En vigur

Inscripziun en il register

Numer da publicaziun
EP3166596
Numer da la dumonda
EP15738484
Gener
Patent europeic cun effect per la Svizra ed il Liechtenstein
Status
En vigur
Scrittira da patent
Concedì
Annunzià
06-07-2015
Publitgà
17-05-2017
Concedì
06-06-2018
La protecziun finescha il pli tard
05-07-2035
Proxima taxa annuala scadenta
31-07-2027
Classas IPC
A61K 9/20 (2006.01)
A61K 31/45 (2006.01)
Prioritad
US 201462021271 P 07.07.2014
Dumonda PCT
PCT/IB2015/055098 06.07.2015
Publicaziun PCT
WO2016/005880 14.01.2016
Lingua da l’annunzia
englais
Funtauna
Swissreg

Istorgia

Quai che l’Institut federal da la proprietad intellectuala ha publitgà davart quest titel, il pli nov l’emprim.

  1. 01-08-2026

    Next annual fee due on

    Next annual fee due on
    31.07.2026 → 31.07.2027

    Published in Swissreg on 01.08.2026

  2. 01-08-2025

    Next annual fee due on

    Next annual fee due on
    31.07.2025 → 31.07.2026

    Published in Swissreg on 01.08.2025

  3. 01-08-2024

    Midada

    Published in Swissreg on 01.08.2024

  4. 01-08-2023

    Midada

    Published in Swissreg on 01.08.2023

  5. 08-08-2022

    Midada

    Published in Swissreg on 08.08.2022

  6. 17-07-2020

    Represchentant inscrit

    Representative
    BOHEST AG, Holbeinstrasse 36-38, 4051 Basel

    Published in Swissreg on 17.07.2020

  7. 17-07-2020

    Transferì

    Owner
    Novartis AG, Lichtstrasse 35, 4056 Basel → Recordati AG, Lindenstrasse 8, 6340 Baar

    Published in Swissreg on 17.07.2020

  8. 06-06-2018

    Concedì

    Published in Swissreg on 06.06.2018

Partidas

Il register numna mintga partida cun num ed adressa. In possessur u in represchentant vegn collià cun in’organisaziun, sch’exact ina unitad giuridica dal register da commerzi porta ses num; la via d’ina partida betg enconuschida uschia na vegn betg mussada qua.